Comorbidity among patients with colon cancer in New Zealand

New Zealand Medical Journal

Volumn 124, Issue 1338, 2011, Pages 76-88

  Sarfati, Diana ^a   Tan, Lavinia ^a   Blakely, Tony ^a   Pearce, Neil ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CANCER PATIENT; CHRONIC RESPIRATORY TRACT DISEASE; COLON CANCER; COMORBIDITY; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEMENTIA; ENTERITIS; ESSENTIAL HYPERTENSION; ETHNICITY; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEMIPLEGIA; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; LENGTH OF STAY; LIVER DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; NEW ZEALAND; OUTCOME ASSESSMENT; PARAPLEGIA; PERIPHERAL VASCULAR DISEASE; SCORING SYSTEM; SEX;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COLONIC NEOPLASMS; COMORBIDITY; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PREVALENCE; RESPIRATORY TRACT DISEASES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 79960271487     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Feinstein A. The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis 1970;23:455-69.
2. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol 2001;54(7):661-74.
3. Hall SF. A user's guide to selecting a comorbidity index for clinical research. J Clin Epidemiol 2006;59(8):849-55.
4. Tooth L, Hockey R, Byles J, Dobson A. Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women. J Clin Epidemiol 2008;61(2):151-9.
5. Davis P, Lay-Yee R, Fitzjohn J, Hider P, Schug S, Briant R, et al. Co-morbidity and health outcomes in three Auckland hospitals. N Z Med J 2002;115(1153):211-5,.
6. Sarfati D, Hill S, Blakely T, Robson B, Purdie G, Dennett E, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer 2009;9:116.
7. Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Chen J, et al. Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Comm Health 2010;64:117-23.
8. Brewer N, Borman B, Sarfati D, Jeffreys M, Fleming ST, Cheng S, et al. Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? In preparation.
9. Sarfati D, Hill S, Purdie G, Dennett E, Blakely T. How well does routine hospitalisation data capture information on comorbidity in New Zealand? NZ Med J 2010;123(1310):50-61.
10. Cunningham R, Sarfati D, Hill S, Dennett E, O'Donnell A. Colon Cancer Management in New Zealand 1996-2003. N Z Med J 2009;122(1294):51-60.
11. Charlson M, Pompei P, Ales K, Mackenzie C. A new method for classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
12. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9- CM administrative databases. J Clin Epidemiol 1992;45(6):613-9.
13. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9- CM administrative data: differing perspectives. J Clin Epidemiol 1993;46(10):1075-9.
14. Young J, Roffers F, Gloeckler Ries L, Fritz A, editors. SEER Summary Staging Manual - 2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute, 2000.
15. Salmond C, Crampton P, Sutton F. NZDep91: A New Zealand index of deprivation. Aust NZ J Public Health 1998;22(7):835-7.
16. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000;35(3):181-200.
17. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000;36(4):453-71.
18. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL, Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291(20):2441-7.
19. Tammemagi C, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA2005;294(14):1765-72.
20. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003;103(6):792-802.
21. Fleming ST, Pearce KA, McDavid K, Pavlov D. The development and validation of a comorbidity index for prostate cancer among Black men. J Clin Epidemiol 2003;56(11):1064-75.
22. Fleming ST, Rastogi A, Dmitrienko A, Johnson KD. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care 1999;37(6):601-14.
23. Hall WH, Jani AB, Ryu JK, Narayan S, Vijayakumar S. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 2005;8(1):22-30.
24. Munro AJ, Bentley AH. Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer. Eur J Cancer Care 2004;13(3):254-62.
25. Newschaffer CJ, Bush TL, Penberthy LE, Bellantoni M, Helzlsour K, Diener-West M. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol A Biol Sci Med Sci 1998;53(5):M372-8.
26. Nuttall M, van der Meulen J, Emberton M. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 2006;59(3):265-73.
27. Singh R, O'Brien TS. Comorbidity assessment in localized prostate cancer: a review of currently available techniques. Eur Urol 2004;46(1):28-41; discussion 41.
28. Iversen LH, Norgaard M, Jacobsen J, Laurberg S, Sorensen HT. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006--a population-based cohort study. Dis Colon Rectum 2009;52(1):71-8.
29. Baldwin L-M, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 2006;44(8):745-53.
30. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36(1):8-27.
31. Ghali WA, Hall RE, Rosen AK, Ash AS, Moskowitz MA. Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1996;49(3):273-8.
32. Humphries KH, Rankin JM, Carere RG, Buller CE, Kiely FM, Spinelli JJ. Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol 2000;53(4):343-9.
33. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol 1997;50(6):725-33.
34. Satariano WA, Silliman RA. Comorbidity: implications for research and practice in geriatric oncology. Crit Rev Oncol Hematol 2003;48(2):239-48.
35. Lund L, Jacobsen J, Clark P, Borre M, Norgaard M, Northern Danish Cancer Quality Assessment G. Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study. Urology 2010;75(2):393-8.
36. Lund L, Borre M, Jacobsen J, Sorensen HT, Norgaard M. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study. Urology 2008;72(6):1258-62.
37. Armitage J, van der Meulen J, on behalf of the Royal College of Surgeons Co-morbidity Consensus Group. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. Brit J Surg 2010;97:772-81.
38. Librero J, Peiro S, Ordinana R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol 1999;52(3):171-9.
39. Malenka DJ, McLerran D, Roos N, Fisher ES, Wennberg JE. Using administrative data to describe casemix: a comparison with the medical record. J Clin Epidemiol 1994;47(9):1027-32.
40. van Doorn C, Bogardus ST, Williams CS, Concato J, Towle VR, Inouye SK. Risk adjustment for older hospitalized persons: a comparison of two methods of data collection for the Charlson index. J Clin Epidemiol 2001;54(7):694-701.